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Introduction: Obsessive-Compulsive Disorder (OCD) as one of the important mental problems 
is valuable topic for proteomic research studies to better understand the underlying mechanisms 
of this disorder. 
Methods: In this paper, gel-based proteomic was used to investigate the proteome profile of 
16 female patients with OCD, washing subtype before and after treatment with fluoxetine and 
comparing them with 20 healthy female controls.
Results: One of the abnormally expressed protein spots in this study was introduced and examined 
for protein-protein interaction network analysis via Cytoscape and its plug-ins. Transthyretin 
(TTR) protein showed significant expression changes (fold change=1.7, P<0.05). While the 
expression level of TTR is significantly decreased in OCD patients before any treatments, the 
trend is partially normalized after treatment with fluoxetine in positive responders. Furthermore, 
TTR interaction profile shows that the proteins interacting with this protein may get affected as 
this protein expression trend changes in OCD patients. 
Conclusion: TTR can be considered for further studies to be validated as a potential biomarker 
for OCD. 
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1. Introduction
bsessive-Compulsive Disorder (OCD) life-
time prevalence is about 1% to 3% on the 
global scale. The typical manifestations of 
this severe condition are intrusive thoughts 
and repetitive behavior (Zamanian-Azodi 
et al., 2015). This complex disorder is known with differ-
ent subtypes and presence of comorbidities. Its complexity 
has been studied via different approaches, including neu-
rochemical, neuroanatomic, genetics, neuroimmunology, 
and animal studies. The conducted investigations support 
the contribution of dimensional genetic and environmental 
factors (Stein, 2000). OCD phenotype, therefore, can be 
influenced by interaction of these factors with each other. 
There are many identified genes from genetic studies that 
are linked to OCD pathogenesis (Taylor, 2013). However, 
their associations lack genome-wide and (eQTLS) approv-
al. Moreover, since complexity of OCD made its analyses 
difficult it in terms of clinical and molecular basis as well as 
identification of treatment protocols, subtype evaluation can 
be helpful (Miguel et al., 2005). Therefore, studying wash-
ing subtype of OCD as one of the common subtypes among 
Iranian women is crucial. Women with this phenotype have 
contamination fear that compel them to perform repetitive 
washing activities (Zamanian-Azodi et al., 2015). The hy-
peractivity of certain parts of the brain are identified for this 
subtype, including bilateral ventromedial prefrontal regions 
and right caudate nucleus (Mataix-Cols et al., 2004). There 
are some introduced genes with washing subtype, including 
ESR1, DLGAP1, HTR3A-E, and GRIN2B (Alonso et al., 
2011; Li et al., 2015; Lennertz et al., 2014; Gratacós, Real, 
Bayés, Labad, & López-Solà, 2012). On the other hand, 
proteome investigation of OCD has not been performed yet. 
Proteomics can provide essential information related to dis-
order in molecular basis. In fact, proteome as the functional 
level of organism, can be identified through proteomics and 
thereby, better understand the underling mechanisms of the 
disorder (Safari-Alighiarloo, Rezaei Tavirani, Taghizadeh, 
Tabatabaei,  & Namaki, 2016). 
Available treatments for OCD are psychotherapy and 
medication prescription. The combination of these two are 
known as the most effective treatment. In addition, the most 
applied medication for OCD is Serotonin Reuptake Inhibi-
tors (SSRIs) (Freitas, Ferreira, Correia, Portinha,  & Correia, 
2016). Fluoxetine is one of the most common types of SSRIs 
for OCD treatment (Gertsema, Reichenberg, & Ripperger-
Suhler, 2016). Fluoxetine effects on human serum proteome 
is also detectable through proteomic evaluations. As serum 
is one of the accessible sources for exploring protein expres-
sion levels (Nejadi, Masti, Tavirani, & Golmohammadi, 
2014; Nejadi et al., 2015), we aimed to assess proteome ex-
pression changes in OCD patients before and after treatment 
with fluoxetine. In this way, we could better understand the 
molecular changes at protein’s level in OCD patients. 
2. Methods
2.1. Sample collection 
2.1.1. Human subjects
A total of 35 women with OCD, washing subtype and 
with moderate severity were selected for this study. The 
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Highlights 
● Transthyretin expression drops in OCD patients and fluoxetine partially compensates this reduction.
Plain Language Summary 
Obsessive-Compulsive Disorder (OCD) is a known mental disorder with several subtypes such as washing subgroup. 
The female patients suffer from this subtype experience a difficult life style. There is no molecular method for diagnosis 
of OCD. Interview is a common way to determine disorder and also patients' follow up.  In this regard, there is serious 
need for a diagnostic reagent for OCD. Since there are many molecules related to OCD, we tried to introduce a suitable 
and accessible molecule (which can be considered as a potential biomarker) that can use as a marker for OCD. One of 
the common used drugs in OCD patients is fluoxetine. Effect of fluoxetine on the presence of this molecular reagent 
was also investigated. The finding from serum of 16 patients compared with 20 healthy women by proteomic methods 
indicates that transthyretin (TTR) concentration drops in the patients and the used drug compensates this reduction 
considerably. This possible biomarker can be used as diagnostic factor or follow up marker of the OCD patients. More 
studies in the larger sample size by focus on TTR concentration on the blood of the patients can lead to support TTR 
role as a valuable biomarker. 
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patients were diagnosed based on DSM-V and enrolled 
in our study from Taleghani Hospital, Tehran, Iran. The 
patients and 20 volunteer healthy controls (without any 
previous record of mental disorder) were demographi-
cally matched. Inclusion criteria were as follows: medi-
cation free women with washing subtype of OCD, with-
out any types of other psychiatric disorder at the time of 
study as well as before the study. The patients were be-
tween 20-30 years old. They were given written informed 
consents prior to their sampling. Two expert physiatrists 
assessed the clinical symptoms before and after treatment 
with medication by using Yale–Brown Obsessive Com-
pulsive Scale (Y-BOCS). The first sampling from OCD 
patients was prior to fluoxetine treatment. After 17 weeks 
of patients’ treatment with fluoxetine (20-60 mg range), 
the treatment resistance cases were excluded and only 
16 samples were remained for further investigation. The 
patients that showed >35% reduction in Y-BOCS scores 
after the treatment were categorized as positive respond-
ers and their blood samples were taken. The proteome of 
the 16 positive responders before and after treatment with 
fluoxetine were compared with healthy control group. 
2.2. Sample preparation
Blood samples were collected by venipuncture using 
gauge needle. The samples were left at room tempera-
ture for 30 min and then centrifuged two times (2000 g) 
at 4ºC. Next, the separated serum samples were trans-
ferred to Eppendorf microtubes and kept at −80°C until 
further process. 
2.3. Proteomic analysis 
All the proteomics materials are purchased from GE 
Health Care Life Sciences1 and SERVA Company2. 2-DE 
Clean-Up Kit (GE Healthcare) was used for proteome 
extraction of our samples. Following the extraction, de-
termination of protein concentration was done by 2-DE 
Quant Kit (GE Healthcare). The first step of separation 
Isoelectric Focusing (IEF) was based on pI. Prior to this 
step, IPG strips were passively rehydrated for 8 hours. 
The separation procedure was taken for 7.5 hours and 
the running condition was based on Bio-Rad Protocol. 
Between separation steps, equilibration is necessary to 
adjust the first step for the second condition. HPE Flat 
Top Tower (horizontal electrophoresis) using 2D HPE™ 
Double-Gel 12.5% Kit (Serva Company) separated pro-
teins based on MW for about 3.5 hours. Finally, after 
2-DE, SERVA HPE™ Coomassie® Staining Kit was ap-
1. http://www.gelifesciences.com
2. http://www.serva.de
plied for staining gels based on the SERVA Protocol. For 
gel analysis, gels were scanned by Bio-Rad Scanner and 
the calibration was set to GS-800 densitometer (Hasan-
zadeh, Rezaie-Tavirani, Seyyedi, & Emadi, 2015). The 
gel analysis was done by Progenesis SameSpots Soft-
ware as multivariate statistical analysis tool analyzing 
gel images using alignment method. The criteria for gel 
analysis were as follow: 1.5-fold change (P<0.05). The 
whole experiment was done three times. 
2.4. Nested pathway network analysis
Interaction analysis was performed by Cytoscape 
3.4.0-Milestone 2 for Transthyretin (TTR) as one of the 
identified proteins in our experiment. TTR (initial protein) 
and its neighbor interacting proteins (enriched proteins) 
were assessed for interaction type and functional anno-
tations by CluePedia application. The action type was 
derived from STRING Action File available in CluePe-
dia panel. Selected actions are activation, binding, ex-
pression, inhibition, post translation modifications. Each 
action is assigned with a specific color. The edge score 
(Kappa Score) is customizable and scores (0-1) can be 
shown as thick and thin lines. Here, it is set to 0.5 (me-
dium) cut off for any actions and also to show the top 
interactions (threshold selection=20 proteins). For func-
tional enrichment analysis based on biological process, 
the threshold was set to 4 terms. In addition, these proteins 
can be visualized as a pathway-like view with pre-defined 
cellular compartments, including extracellular, plasma 
membrane, intracellular, nuclear membrane, nucleus, and 
transcription factor complex (Bindea et al., 2009). 
3. Results
The expression changes of one of the differentially ex-
pressed proteins in this study can be inferred from Fig-
ures 1 and 2. The changes range from control to drug-
naïve OCD, and drug-treated samples. The interaction 
analysis of TTR is provided by the use of Cytoscape 
Plug-in, CluePedia (Figures 3 and 4).
4. Discussion
Performing proteomics in OCD patients before and after 
treatment with fluoxetine provides essential information 
related to proteome expression changes in these conditions. 
Some of the proteins with significant expression alterations 
may be considered as potential biomarkers after extensive 
validation studies. Here, among the identified spots in 2D 
gel electrophoresis, only one of the significant differen-
tially expressed proteins, is examined and described. The 
candidate protein showed some expression levels’ changes 
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in patients with OCD before and after treatment with fluox-
etine for 17 weeks. As shown in Figure 1, this trend is de-
creased in drug-naïve patients while it is half way returned 
to its volume in treated samples. That means, the expres-
sion levels in patients with OCD before taking fluoxetine 
abnormally reduces and after prescription of fluoxetine for 
17 weeks, this amount is half way normalized. This spot 
was sought against http://world-2dpage.expasy.org/swiss-
2dpage/ and based on pI and MW, it was recognized as one 
of the isoforms of TTR protein. 
Other isoforms of TTR did not show significant expres-
sion alterations in our samples. This protein is a highly 
conserved serum protein with many functions. It is se-
creted from the liver and transports thyroid hormone (T4) 
and Retinol-Binding Protein 4 (RBP4) and its retinol li-
gand. Many metabolic and septic disorders are related to 
dysfunction of TTR (Sullivan et al., 2006; Ingenbleek & 
Bernstein, 2015). In addition, TTR is also important in 
some brain diseases such as Alzheimer disease (White et 
al., 2015), schizophrenia (Yang et al., 2006), and depres-
sion (Sousa et al., 2004). It is reported that low levels of 
CSF-TTR has some correlation with serotonergic hypo-
function in depression (Sullivan et al., 2006). In addition, 
TTR decrement is linked to acute phase response that 
could be related to inflammation (Chiaradia et al., 2012). 
Figure 1. Expression pattern of the differentially expressed protein in control, OCD and drug treated samples of 2DE Gel
The experiment was repeated three times by Same Spots software. The pI and MW of this spot were 5 and 1300, respectively. 
The left panel shows protein spot properties including spot number, P value, and fold change. Fold changes (control-OCD)=1.7 
and (OCD-Drug)=1.3 , P(ANOVA)=2.32E-09. Power=0.99. Q value (corrected P value)=2.32E-09. In the right corner of the im-
age, the whole pattern of proteome profile is apparent. The red parts are not included for the alignment. The MW ladder is on 
the right side of the gel. 
Figure 2. The dendrogram analysis based on hierarchical clustering and automatic correlation analysis
The clustering explains expression pattern of each protein in three samples. The distance between groups implies the expres-
sion difference. TTR belongs to the second cluster. The position of this protein is highlighted in red. The vertical axis for expres-
sion pattern corresponds to the normalized volume of the spot. 
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The contribution of immune system in mental disorders 
including OCD (Konuk et al., 2007), is in agreement 
with our finding. Furthermore, as fluoxetine changes 
protein expression of TTR, this shows that it may have 
some positive regulatory effect on its levels in serum. On 
the other hand, it has been reported that fluoxetine im-
pose structural changes in some proteins (Rezaei-Tavi-
rani et al., 2011; Shahani et al., 2013). Hence, fluoxetine 
may have some effects on both structure and expression 
levels of some proteins. 
Based on Figure 2, TTR belongs to the second cluster 
of protein expression profile. Proteins within sub-clus-
ters may show similar annotations. Therefore, gene on-
tology analysis of proteins with similar expression pat-
terns is essential for possibly identifying the role of other 
unknown proteins within same sub-clusters (Rezaei-Ta-
virani Rahmati Rad, Rezaei Tavirani, 2016). Therefore, 
proteins within same cluster as TTR may show similar 
annotations to this protein. As the expression pattern of 
TTR alters in OCD patients, other proteins in interaction 
may be influenced. In this regard, TTR protein neigh-
bors may get affected by the dysregulation of TTR. As 
it is shown in Figure 3, there is no inhibitory interaction 
between TTR and its 20 neighbor proteins. Five activa-
tor edges directed to the TTR are highlighted in Figure 
3. Therefore, TTR function is balanced in a basic state in 
physiologic condition and positive regulation is the main 
regulatory activity for evaluation of its role. Returning 
to the physiological condition, requires decrement of 
activatory regulation. FOXM1 is the unique node that 
affects directly TTR expression rate. Thus, expression of 
FOXM1 may be changed as well. Moreover, one of the 
important binding proteins in TTR network is insulin. 
Insulin was previously recognized as one of the key pro-
teins interacting with the identified metabolites of OCD 
(Zamanian-Azodi, Mortazavi Tabatabaei, Mansouri, & 
Vafaee, 2016). This finding may provide additional vali-
dation of the possible contribution of insulin in OCD 
pathophysiology. 
The highlighted role of insulin in this study indicated 
the involvement of metabolite pathways such as carbo-
hydrate metabolism and sugar regulation in body and in 
OCD patients. However, regulatory role of insulin in the 
other biological processes implies its importance in this 
disorder. APP is another protein that binds to TTR and its 
role in mental disorders is reported (Seidel et al., 1995; 
Jakobsson et al., 2013). Moreover, annotation analysis 
showed that regulation of response to oxidative stress, 
gluconeogenesis, retinoid metabolic, and endocrine pan-
creas development are the processes related to the ob-
tained nested-network. These processes may be altered 
by dysregulation of the correlated proteins; yet, more 
examination is required to clarify it. TTR has vast in-
Figure 3. The interaction analysis of Transthyretin (TTR) 
with neighbor proteins and their related four top ranked 
biological processes (BP) colored in gray, obtained by Clue-
Pedia plug-in
Added proteins are colored turquoise. Different edge colors 
imply on different actions. Blue=Binding; Green=Activation; 
Yellow=Expression; Red= Inhibition
Figure 4. A pathway-like view of the network showing cel-
lular locations’ of TTR and the rest of 20 proteins
The location of biological processes are also clear in this 
Figure. These parts are coded as 1 (extracellular), 2 (plasma 
membrane), 3 (intracellular), and 5 (nucleus). Most of the 
processes are in extracellular and intracellular compart-
ments. In addition, most of the proteins are located in intra-
cellular part
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teractions with different parts of a cell as indicated in a 
cerebral view in Figure 4. 
Proteins connected to TTR are organized in extracel-
lular, plasma membrane, intracellular, and nucleus. In 
addition, intracellular part is the highlighted location 
for most of the retrieved interacting proteins with TTR. 
Moreover, TTR and INS seem to be present at the similar 
cellular components. This finding supports the significant 
roles of the two biomarkers in metabolite network. Con-
sequently, one of the differences between normal people 
and patients with OCD is the expression changes of TTR 
protein in the human serum. As the first known proteomic 
study, we propose the association of TTR to the OCD 
pathogenicity. The findings indicate that one of the iso-
forms of TTR shows significant down-regulation pattern 
in OCD patients and can be considered as a potential bio-
marker after extensive validation studies. Furthermore, 
fluoxetine may contribute in positive regulation of TTR 
expression levels in serum. Similarly, for this aim, valida-
tion methods should be considered. On the whole, it can 
be suggested that further monitoring of TTR as a possible 
candidate biomarker may help better understand the mo-
lecular alteration and pathways involved in OCD patients 
as well as clinical response to fluoxetine. 
In conclusion, proteomics introduce TTR as a signifi-
cant altered protein in expression levels in OCD. Con-
sequently, TTR may be considered as a novel serum 
indicator of OCD pathophysiology after implementing 
extensive validation approaches. In addition to TTR, it 
was determined that the other agents especially insulin 
may play crucial roles in OCD; however, the major role 
of TTR is highlighted. 
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